New Jersey S 301: Provides that purchase of insulin is not subject to deductible and requires health insurers to limit copayments and coinsurance for insulin.

Status: Introduced in the Senate, Referred to Senate Commerce Committee (as of 2022-01-11)

State: New Jersey · Session: 220 · Bill: S 301

Subjects: DISEASE, HEALTH INSUR, PHARMACEUTIC

Sponsors: Pou, Nellie, Vitale, Joseph F., Gopal, Vin, Lagana, Joseph A., Madden, Fred H., Ruiz, M. Teresa, Turner, Shirley K., Zwicker, Andrew

View New Jersey S 301 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.